Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Casey

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Psychiatry|May 11, 2001
Antipsychotic-induced weight gain: a review of the literatureD B Allison, D E Casey
Modern Problems of Pharmacopsychiatry|January 1, 1983
Neuroleptic treatment in tardive dyskinesia: can it be developed into a clinical strategy for long-term treatment?D E Casey, L M Toenniessen
Biochemical Pharmacology|August 15, 1988
Development and characterization of anti-spiroperidol antibodiesK A Neve, D E Casey
Psychopharmacology|January 1, 1980
Enkephalin, morphine, and naloxone in tardive dyskinesiaN Bjørndal, D E Casey, J Gerlach
Psychiatry Research|April 1, 1983
Effect of gamma-vinyl GABA in tardive dyskinesiaS Korsgaard, D E Casey, J Gerlach
Psychopharmacology|January 1, 1980
Dopamine, acetylcholine, and GABA effects in acute dystonia in primatesD E Casey, J Gerlach, E Christensson
Psychopharmacology|January 1, 1982
High-dose destyrosine-gamma-endorphin in tardive dyskinesiaS Korsgaard, D E Casey, J Gerlach
Psychopharmacology|January 1, 1982
Levodopa and receptor sensitivity modification in tardive dyskinesiaD E Casey, J Gerlach, N Bjørndal
The American Journal of Psychiatry|May 1, 1979
Neuroleptic-potentiating effect of metyrosineG Magelund, J Gerlach, D E Casey
Psychopharmacology|January 1, 1979
Sulpiride in tardive dyskinesiaD E Casey, J Gerlach, H Simmelsgaard
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Psychiatry|May 11, 2001
Antipsychotic-induced weight gain: a review of the literatureD B Allison, D E Casey
Modern Problems of Pharmacopsychiatry|January 1, 1983
Neuroleptic treatment in tardive dyskinesia: can it be developed into a clinical strategy for long-term treatment?D E Casey, L M Toenniessen
Biochemical Pharmacology|August 15, 1988
Development and characterization of anti-spiroperidol antibodiesK A Neve, D E Casey
Psychopharmacology|January 1, 1980
Enkephalin, morphine, and naloxone in tardive dyskinesiaN Bjørndal, D E Casey, J Gerlach
Psychiatry Research|April 1, 1983
Effect of gamma-vinyl GABA in tardive dyskinesiaS Korsgaard, D E Casey, J Gerlach
Psychopharmacology|January 1, 1980
Dopamine, acetylcholine, and GABA effects in acute dystonia in primatesD E Casey, J Gerlach, E Christensson
Psychopharmacology|January 1, 1982
High-dose destyrosine-gamma-endorphin in tardive dyskinesiaS Korsgaard, D E Casey, J Gerlach
Psychopharmacology|January 1, 1982
Levodopa and receptor sensitivity modification in tardive dyskinesiaD E Casey, J Gerlach, N Bjørndal
The American Journal of Psychiatry|May 1, 1979
Neuroleptic-potentiating effect of metyrosineG Magelund, J Gerlach, D E Casey
Psychopharmacology|January 1, 1979
Sulpiride in tardive dyskinesiaD E Casey, J Gerlach, H Simmelsgaard
Pageof 13